The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagaoka, I.
Right arrow Articles by Heumann, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagaoka, I.
Right arrow Articles by Heumann, D.
The Journal of Immunology, 2001, 167: 3329-3338.
Copyright © 2001 by The American Association of Immunologists

Cathelicidin Family of Antibacterial Peptides CAP18 and CAP11 Inhibit the Expression of TNF-{alpha} by Blocking the Binding of LPS to CD14+ Cells1

Isao Nagaoka2,*, Satoko Hirota*, François Niyonsaba*, Michimasa Hirata{dagger}, Yoshiyuki Adachi{ddagger}, Hiroshi Tamura and Didier Heumann

* Department of Biochemistry, Juntendo University School of Medicine, Tokyo, Japan; {dagger} Research Division of Innate Immunity, Matsuzono Pharmacy, Iwate, Japan; {ddagger} Laboratory of Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Science School of Pharmacy, Tokyo, Japan; § Central Research Laboratories, Seikagaku Corporation, Tokyo, Japan; and Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois-Lausanne, Lausanne, Switzerland

Mammalian myeloid and epithelial cells express several kinds of antibacterial peptides ({alpha}-/{beta}-defensins and cathelicidins) that contribute to the innate host defense by killing invading micro-organisms. In this study we evaluated the LPS-neutralizing activities of cathelicidin peptides human CAP18 (cationic antibacterial proteins of 18 kDa) and guinea pig CAP11 using the CD14+ murine macrophage cell line RAW264.7 and the murine endotoxin shock model. Flow cytometric analysis revealed that CAP18 and CAP11 inhibited the binding of FITC-conjugated LPS to RAW264.7 cells. Likewise, Northern and Western blot analyses indicated that CAP18 and CAP11 suppressed LPS-induced TNF-{alpha} mRNA and protein expression by RAW264.7 cells. Interestingly, CAP18 and CAP11 possessed LPS-binding activities, and they strongly suppressed the interaction of LPS with LPS binding protein that mediates the transport of LPS to CD14 to facilitate the activation of CD14+ cells by LPS. Moreover, when CAP18 and CAP11 were preincubated with RAW264.7 cells, they bound to the cell surface CD14 and inhibited the binding of FITC-LPS to the cells. Furthermore, in the murine endotoxin shock model, CAP18 or CAP11 administration inhibited the binding of LPS to CD14+ cells (peritoneal macrophages) and suppressed LPS-induced TNF-{alpha} expression by these cells. Together these observations indicate that cathelicidin peptides CAP18 and CAP11 probably exert protective actions against endotoxin shock by blocking the binding of LPS to CD14+ cells, thereby suppressing the production of cytokines by these cells via their potent binding activities for LPS and CD14.




This article has been cited by other articles:


Home page
Int ImmunolHome page
T. Murakami, T. Obata, K. Kuwahara-Arai, H. Tamura, K. Hiramatsu, and I. Nagaoka
Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice
Int. Immunol., August 1, 2009; 21(8): 905 - 912.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Miles, D. J. Clarke, W. Lu, Z. Sibinska, P. E. Beaumont, D. J. Davidson, T. A. Barr, D. J. Campopiano, and M. Gray
Dying and Necrotic Neutrophils Are Anti-Inflammatory Secondary to the Release of {alpha}-Defensins
J. Immunol., August 1, 2009; 183(3): 2122 - 2132.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Wittmann, M. Schonefeld, D. Aichele, G. Groer, A. Gessner, and M. Schnare
Murine Bactericidal/Permeability-Increasing Protein Inhibits the Endotoxic Activity of Lipopolysaccharide and Gram-Negative Bacteria
J. Immunol., June 1, 2008; 180(11): 7546 - 7552.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
N. Beckloff, D. Laube, T. Castro, D. Furgang, S. Park, D. Perlin, D. Clements, H. Tang, R. W. Scott, G. N. Tew, et al.
Activity of an Antimicrobial Peptide Mimetic against Planktonic and Biofilm Cultures of Oral Pathogens
Antimicrob. Agents Chemother., November 1, 2007; 51(11): 4125 - 4132.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K.-F. Wong, J. M. Luk, R. H. Cheng, L. B. Klickstein, and S.-T. Fan
Characterization of two novel LPS-binding sites in leukocyte integrin {beta}A domain
FASEB J, October 1, 2007; 21(12): 3231 - 3239.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
J. Andra, T. Gutsmann, P. Garidel, and K. Brandenburg
Invited review: Mechanisms of endotoxin neutralization by synthetic cationic compounds
Innate Immunity, October 1, 2006; 12(5): 261 - 277.
[Abstract] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. Okuda, S. Yomogida, H. Tamura, and I. Nagaoka
Determination of the Antibacterial and Lipopolysaccharide-Neutralizing Regions of Guinea Pig Neutrophil Cathelicidin Peptide CAP11.
Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2602 - 2607.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. Motzkus, S. Schulz-Maronde, A. Heitland, A. Schulz, W.-G. Forssmann, M. Jubner, and E. Maronde
The novel {beta}-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo
FASEB J, August 1, 2006; 20(10): 1701 - 1702.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Nagaoka, H. Tamura, and M. Hirata
An Antimicrobial Cathelicidin Peptide, Human CAP18/LL-37, Suppresses Neutrophil Apoptosis via the Activation of Formyl-Peptide Receptor-Like 1 and P2X7.
J. Immunol., March 1, 2006; 176(5): 3044 - 3052.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Rosenfeld, N. Papo, and Y. Shai
Endotoxin (Lipopolysaccharide) Neutralization by Innate Immunity Host-Defense Peptides: PEPTIDE PROPERTIES AND PLAUSIBLE MODES OF ACTION
J. Biol. Chem., January 20, 2006; 281(3): 1636 - 1643.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. Liu, C. C. Cramer, J. Scafidi, and A. E. Davis III
N-Linked Glycosylation at Asn3 and the Positively Charged Residues within the Amino-Terminal Domain of the C1 Inhibitor Are Required for Interaction of the C1 Inhibitor with Salmonella enterica Serovar Typhimurium Lipopolysaccharide and Lipid A
Infect. Immun., August 1, 2005; 73(8): 4478 - 4487.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
D. M.E. Bowdish and R. E.W. Hancock
Anti-endotoxin properties of cationic host defence peptides and proteins
Innate Immunity, August 1, 2005; 11(4): 230 - 236.
[Abstract] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. W. McMichael, A. Roghanian, L. Jiang, R. Ramage, and J.-M. Sallenave
The Antimicrobial Antiproteinase Elafin Binds to Lipopolysaccharide and Modulates Macrophage Responses
Am. J. Respir. Cell Mol. Biol., May 1, 2005; 32(5): 443 - 452.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
R. S. Munford
Invited review: Detoxifying endotoxin: time, place and person
Innate Immunity, April 1, 2005; 11(2): 69 - 84.
[Abstract] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Borregaard, K. Theilgaard-Monch, J. B. Cowland, M. Stahle, and O. E. Sorensen
Neutrophils and keratinocytes in innate immunity--cooperative actions to provide antimicrobial defense at the right time and place
J. Leukoc. Biol., April 1, 2005; 77(4): 439 - 443.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. V. Bocharov, I. N. Baranova, T. G. Vishnyakova, A. T. Remaley, G. Csako, F. Thomas, A. P. Patterson, and T. L. Eggerman
Targeting of Scavenger Receptor Class B Type I by Synthetic Amphipathic {alpha}-Helical-containing Peptides Blocks Lipopolysaccharide (LPS) Uptake and LPS-induced Pro-inflammatory Cytokine Responses in THP-1 Monocyte Cells
J. Biol. Chem., August 20, 2004; 279(34): 36072 - 36082.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Elssner, M. Duncan, M. Gavrilin, and M. D. Wewers
A Novel P2X7 Receptor Activator, the Human Cathelicidin-Derived Peptide LL37, Induces IL-1{beta} Processing and Release
J. Immunol., April 15, 2004; 172(8): 4987 - 4994.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. Liu, X. Gu, J. Scafidi, and A. E. Davis III
N-Linked Glycosylation Is Required for C1 Inhibitor-Mediated Protection from Endotoxin Shock in Mice
Infect. Immun., April 1, 2004; 72(4): 1946 - 1955.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. E. Bowdish, D. J. Davidson, D. P. Speert, and R. E. W. Hancock
The Human Cationic Peptide LL-37 Induces Activation of the Extracellular Signal-Regulated Kinase and p38 Kinase Pathways in Primary Human Monocytes
J. Immunol., March 15, 2004; 172(6): 3758 - 3765.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. M. Shasby and P. McCray
Sepsis and Innate Immunity
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 144 - 145.
[Full Text] [PDF]


Home page
J. Immunol.Home page
S. E. Sweeney and Y. B. Kim
Identification of a Novel Fc{gamma}RIIIa{alpha}-Associated Molecule That Contains Significant Homology to Porcine Cathelin
J. Immunol., January 15, 2004; 172(2): 1203 - 1212.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. S. Tjabringa, J. Aarbiou, D. K. Ninaber, J. W. Drijfhout, O. E. Sorensen, N. Borregaard, K. F. Rabe, and P. S. Hiemstra
The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor
J. Immunol., December 15, 2003; 171(12): 6690 - 6696.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Ohgami, I. B. Ilieva, K. Shiratori, E. Isogai, K. Yoshida, S. Kotake, T. Nishida, N. Mizuki, and S. Ohno
Effect of Human Cationic Antimicrobial Protein 18 Peptide on Endotoxin-Induced Uveitis in Rats
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4412 - 4418.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Liu, S. Cai, X. Gu, J. Scafidi, X. Wu, and A. E. Davis III
C1 Inhibitor Prevents Endotoxin Shock Via a Direct Interaction with Lipopolysaccharide
J. Immunol., September 1, 2003; 171(5): 2594 - 2601.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. E. Sorensen, L. Gram, A. H. Johnsen, E. Andersson, S. Bangsboll, G. S. Tjabringa, P. S. Hiemstra, J. Malm, A. Egesten, and N. Borregaard
Processing of Seminal Plasma hCAP-18 to ALL-38 by Gastricsin: A NOVEL MECHANISM OF GENERATING ANTIMICROBIAL PEPTIDES IN VAGINA
J. Biol. Chem., August 1, 2003; 278(31): 28540 - 28546.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Tsutsumi-Ishii and I. Nagaoka
Modulation of Human {beta}-Defensin-2 Transcription in Pulmonary Epithelial Cells by Lipopolysaccharide-Stimulated Mononuclear Phagocytes Via Proinflammatory Cytokine Production
J. Immunol., April 15, 2003; 170(8): 4226 - 4236.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
I. Nagaoka, S. Hirota, F. Niyonsaba, M. Hirata, Y. Adachi, H. Tamura, S. Tanaka, and D. Heumann
Augmentation of the Lipopolysaccharide-Neutralizing Activities of Human Cathelicidin CAP18/LL-37-Derived Antimicrobial Peptides by Replacement with Hydrophobic and Cationic Amino Acid Residues
Clin. Vaccine Immunol., September 1, 2002; 9(5): 972 - 982.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.